During the past decade, Unità Operativa Complessa di Ematologia - Arcispedale S. Maria Nuova conducted 36 clinical trials. In the 10-year time frame, 36 clinical trials started and 5 clinical trials were completed, i.e. on average, 13.9% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 1 clinical trials were completed. i.e. 5.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Unità Operativa Complessa di Ematologia - Arcispedale S. Maria Nuova" #1 sponsor was "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 32 trials, followed by "Fondazione Italiana Linfomi ONLUS" with 23 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored, "Celgene" with 3 trials sponsored and "Celgene Corporation" with 3 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Unità Operativa Complessa di Ematologia - Arcispedale S. Maria Nuova" #1 collaborator was "Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte" with 3 trials as a collaborator, "Janssen-Cilag S.p.A." with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "ERIC Group" with 1 trials as a collaborator and "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Unità Operativa Complessa di Ematologia - Arcispedale S. Maria Nuova" are "Chronic Myeloid Leukemia" (6 trials), "Acute Myeloid Leukemia" (4 trials), "Chronic Lymphocytic Leukemia" (4 trials), "Multiple Myeloma" (4 trials) and "Follicular Lymphoma" (3 trials). Many other conditions were trialed in "Unità Operativa Complessa di Ematologia - Arcispedale S. Maria Nuova" in a lesser frequency.

Most popular intervention types in "Unità Operativa Complessa di Ematologia - Arcispedale S. Maria Nuova" are "Drug" (44 trials), "Other" (12 trials), "Procedure" (2 trials), "Behavioral" (1 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Rituximab" (5 trials), "Venetoclax" (4 trials), "Dexamethasone" (3 trials), "Ibrutinib" (3 trials) and "Cyclophosphamide" (2 trials). Other intervention names were less common.

The vast majority of trials in "Unità Operativa Complessa di Ematologia - Arcispedale S. Maria Nuova" are 64 trials for "All" genders.

Currently, there are NaN active trials in "Unità Operativa Complessa di Ematologia - Arcispedale S. Maria Nuova". 2 are not yet recruiting, 15 are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Unità Operativa Complessa di Ematologia - Arcispedale S. Maria Nuova, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Unità Operativa Complessa di Ematologia - Arcispedale S. Maria Nuova, 2 "Phase 1" clinical trials were conducted, 25 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".